- Mailing Address:
- School of Pharmacy
- University of Wisconsin
- 777 Highland Avenue
- Madison, WI 53705-2222
- Office:
- 2557 Rennebohm Hall
- Phone: 608-265-9765 Email: legenza@wisc.edu
- Social and Administrative Sciences Division

Laurel Legenza, PharmD, MS
UW Institute for Clinical and Translational Research TL1 Postdoctoral Fellow
Director of Global Health
Legenza L, Nickman N, Drews FA, Tigh J, Rim M, Kelly MP, Tyler LS. Perceived workload assessed using the NASA Task Load Index in academic health center community pharmacies before and after implementation of a central call center. Am J Health-Syst Pharm. 2019;76(21):1794-1805. PMID: 31612926
Legenza L, Barnett S, Lacy J, See C, Desotell N, Eibergen A, Piccirillo J, Rose W. Geographic mapping of Escherichia coli susceptibility: development of a novel clinical decision support tool. Antimicrob Agents Chemother. 2019;63(6):e00048-19. PMID: 30936105
Wenthur CJ, Legenza L, Weinfurter N, Lorenzen A, Bowen D. The Pharmacists Role in Combating Statewide Epidemics. J Pharm Soc Wis. 2019;22(2):8-20.
Legenza L, Barnett S, Rose W, Emmerling T, Peh KH, Safdar N, Coetzee R. Clostridium difficile infection perceptions and practices in South Africa. Antimicrob Resist Infect Control. 2018;7:125. PMID: 30386594
Legenza L, Barnett S, Rose W, Bianchini M, Safdar N, Coetzee R. The epidemiology and outcomes of Clostridium difficile infection among hospitalised patients in South Africa: results of a multicenter retrospective study. BMJ Global Health. 2018;3:e000889. PMID: 30057799
Legenza L, Barnett S, Rose W. Antimicrobial stewardship culture and use of antimicrobial resistance data in clinical practice. J Pharm Soc Wis. 2018;21(4):49-53.
Legenza L, Barnett S, Rose W. Vaccines in development for the primary prevention of Clostridium difficile infection. J Am Pharm Assoc. 2017;57:547-549. PMID: 28712463